161 related articles for article (PubMed ID: 28254701)
1. Design, synthesis and biological evaluation of gentiopicroside derivatives as potential antiviral inhibitors.
Wu S; Yang L; Sun W; Si L; Xiao S; Wang Q; Dechoux L; Thorimbert S; Sollogoub M; Zhou D; Zhang Y
Eur J Med Chem; 2017 Apr; 130():308-319. PubMed ID: 28254701
[TBL] [Abstract][Full Text] [Related]
2. Research Progress of Natural Product Gentiopicroside - a Secoiridoid Compound.
Wu S; Ning Y; Zhao Y; Sun W; Thorimbert S; Dechoux L; Sollogoub M; Zhang Y
Mini Rev Med Chem; 2017; 17(1):62-77. PubMed ID: 27342232
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and anti-influenza viral activities of 1,3-diarylprop-2-en-1-ones: a novel class of neuraminidase inhibitors.
Kinger M; Park YD; Park JH; Hur MG; Jeong HJ; Park SJ; Lee WS; Kim SW; Yang SD
Arch Pharm Res; 2012 Mar; 35(4):633-8. PubMed ID: 22553055
[TBL] [Abstract][Full Text] [Related]
4. Secoiridoid analogues from the fruits of Ligustrum lucidum and their inhibitory activities against influenza A virus.
Pang X; Zhao JY; Yu HY; Yu LY; Wang T; Zhang Y; Gao XM; Han LF
Bioorg Med Chem Lett; 2018 May; 28(9):1516-1519. PubMed ID: 29625823
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of pyrimidine nucleoside monophosphate prodrugs targeted against influenza virus.
Meneghesso S; Vanderlinden E; Stevaert A; McGuigan C; Balzarini J; Naesens L
Antiviral Res; 2012 Apr; 94(1):35-43. PubMed ID: 22306172
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of novel L-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors.
Wang H; Xu R; Shi Y; Si L; Jiao P; Fan Z; Han X; Wu X; Zhou X; Yu F; Zhang Y; Zhang L; Zhang L; Zhou D; Xiao S
Eur J Med Chem; 2016 Mar; 110():376-88. PubMed ID: 26866456
[TBL] [Abstract][Full Text] [Related]
7. In vitro antiviral effects and 3D QSAR study of resveratrol derivatives as potent inhibitors of influenza H1N1 neuraminidase.
Li C; Fang JS; Lian WW; Pang XC; Liu AL; Du GH
Chem Biol Drug Des; 2015 Apr; 85(4):427-38. PubMed ID: 25185493
[TBL] [Abstract][Full Text] [Related]
8. Inhibitors of influenza viruses replication: a patent evaluation (WO2013019828).
Xie Y; Song W; Xiao W; Gu C; Xu W
Expert Opin Ther Pat; 2013 Nov; 23(11):1517-24. PubMed ID: 23967861
[TBL] [Abstract][Full Text] [Related]
9. Conjugates of a secoiridoid glucoside with a phenolic glucoside from the flower buds of Lonicera japonica Thunb.
Kashiwada Y; Omichi Y; Kurimoto S; Shibata H; Miyake Y; Kirimoto T; Takaishi Y
Phytochemistry; 2013 Dec; 96():423-9. PubMed ID: 24120297
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of crenatoside analogues as novel influenza neuraminidase inhibitors.
Chen BL; Wang YJ; Guo H; Zeng GY
Eur J Med Chem; 2016 Feb; 109():199-205. PubMed ID: 26774928
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antiviral activity of formycin derivatives with anti-influenza virus activity.
Takada H; Takizawa N; Shibasaki S; Asaba H; Igarashi M; Shibasaki M; Takahashi Y
Bioorg Med Chem; 2022 Mar; 57():116613. PubMed ID: 35092894
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Biological Evaluation of Strictosamide Derivatives with Improved Antiviral and Antiproliferative Activities.
Li Z; Li Z; Lin Y; Meng Z; Ding G; Cao L; Li N; Liu W; Xiao W; Wu X; Xu J
Chem Biol Drug Des; 2015 Oct; 86(4):523-30. PubMed ID: 25589048
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design.
Chand P; Babu YS; Bantia S; Chu N; Cole LB; Kotian PL; Laver WG; Montgomery JA; Pathak VP; Petty SL; Shrout DP; Walsh DA; Walsh GM
J Med Chem; 1997 Dec; 40(25):4030-52. PubMed ID: 9406595
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anti-influenza activity of aminoalkyl rupestonates.
Zhao J; Aisa HA
Bioorg Med Chem Lett; 2012 Mar; 22(6):2321-5. PubMed ID: 22341943
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of a new series of substituted acyl(thio)urea and thiadiazolo [2,3-a] pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase.
Sun C; Zhang X; Huang H; Zhou P
Bioorg Med Chem; 2006 Dec; 14(24):8574-81. PubMed ID: 16979342
[TBL] [Abstract][Full Text] [Related]
16. Iridoid and bis-iridoid glucosides from the fruit of Gardenia jasminoides.
Li HB; Yu Y; Wang ZZ; Dai Y; Gao H; Xiao W; Yao XS
Fitoterapia; 2013 Jul; 88():7-11. PubMed ID: 23567862
[TBL] [Abstract][Full Text] [Related]
17. A novel class of potent influenza virus inhibitors: polysubstituted acylthiourea and its fused heterocycle derivatives.
Sun C; Huang H; Feng M; Shi X; Zhang X; Zhou P
Bioorg Med Chem Lett; 2006 Jan; 16(1):162-6. PubMed ID: 16216505
[TBL] [Abstract][Full Text] [Related]
18. The clinical need for new antiviral drugs directed against influenza virus.
McCullers JA
J Infect Dis; 2006 Mar; 193(6):751-3. PubMed ID: 16479505
[No Abstract] [Full Text] [Related]
19. Construction and synthesis of tricyclic matrinic derivatives against influenza A virus by privileged structure strategy.
Jiang J; Zhao X; Niu T; Yan H; Yinghong LI; Yuhuan LI; Song D; Tang S; Xing J
Pharmazie; 2019 May; 74(5):265-269. PubMed ID: 31109395
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and anti-influenza A virus activity of novel 2,4-disubstituted quinazoline derivatives.
Wang M; Zhang G; Wang Y; Wang J; Zhu M; Cen S; Wang Y
Bioorg Med Chem Lett; 2020 Jun; 30(11):127143. PubMed ID: 32273213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
